EC challenges Belgium over laboratory practices:
This article was originally published in Clinica
The European Commission has asked Belgium to change the conditions for reimbursement of medical analyses. The Commission has served Belgium with a Reasoned Opinion, asking it to modify certain provisions of Royal Decree 143 of December 30 1982, whereby non-Belgian laboratories are at a disadvantage compared to certain Belgian professionals. Only laboratories which meet the "restrictive conditions imposed by this Royal Decree", the Commission stated last week, may provide services eligible for reimbursement by the sickness insurance scheme, thus discouraging people covered by this from using laboratories which do not meet these conditions, in contravention of Article 43 of the EC Treaty on the freedom of establishment. Belgium has two months to respond, after which time the Commission may refer the case to the Court of Justice.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.